Market Overview The non-Hodgkin lymphoma therapeutics market is personalizing as precision medicine approach drives lymphoma care across molecular subtyping and biomarker-guided therapy. The Non-Hodgkin Lymphoma Therapeutics Market is projected to grow through 2035, driven by genomic profiling adoption, minimal residual disease monitoring, and predictive biomarker validation supporting improved...